Carboxyamidotriazole
羧胺三唑
Report date: 2026/04/28 20:00:22
NME
Base Information
Drug NameCarboxyamidotriazole
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[16]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesGuangdong Yinzhu Pharmaceutical Technology Co Ltd
Inactive CompaniesNational Institutes Of Health Clinical Center (Cc)National Cancer InstituteGuangdong Yinzhu Group Co Ltd +[4]
Active Indications
Inactive Indications +[15]
Other Information
ATC CodeN/A
Related LinksWikipedia